BP000453-IHA-017: Influenza-B Virus Tokio/53/99
Serological studies of influenza B virus, immunogen for antibody production. Tested with anti-influenza B monoclonal antibodies in ELISA.
Purity > 90%, by SDS-PAGE.
Formulation: The B/Tokio/53/99solution (1.7 mg/ml) contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.- BP000453-IHA-016: Influenza-B Virus Qingdao/102/91
Serological studies of influenza B virus, immunogen for antibody production. Tested with anti-influenza B monoclonal antibodies in ELISA.
Purity > 90%, by SDS-PAGE. BP000453-IHA-015: Recombinant Influenza-B Virus Ohio 01/05
Source: Baculovirus Insect Cells-derived.
Immunological Activity: Western-Blot 0.1 ug-1 ug per strip, ELISA 1 ug/Well.
Purity > 90%, by SDS-PAGE.BP000452-IHA-013: Recombinant H9N2 Influenza-A Virus Hong-Kong/1073/99
Source: Baculovirus Insect Cells-derived.
Purity > 90%, by SDS-PAGE.
Immunological Activity: Western-Blot 0.1 ug-1 ug per strip, ELISA 1 ug/Well.BP000451-IHA-009: Recombinant H7N7 Influenza-A Virus Netherlands/219/03
Source: Baculovirus Insect Cells-derived.
Purity > 90%, by SDS-PAGE.
Immunological Activity: Western-Blot 0.1 ug-1ug per strip, ELISA 1 ug/Well.BP000446-SIV-114: Recombinant SIV p55
Source: Baculovirus Insect Cells-derived.
Purity > 90%, by SDS-PAGE and RP-HPLC.BP000445-HIV-002: Recombinant HIV-2 Protease
Source: E. coli-derived.
Predicted molecular mass: 10.7 kDa.BP000442-HIV-140: Recombinant HIV-2 Envelope
Source: E. coli-derived.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000441-HIV-131: Recombinant HIV-1 envelope conjugated to HIV-2 gp39
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-1, HIV type O & HIV-2 infected individuals.
Purity > 95%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000439-HIV-001: Recombinant HIV-1 Protease
Source: E. coli-derived.